Inuvo (CD5) Stock Forecast & Price Target
CD5 Analyst Ratings
CD5 Stock 12 Month Forecast
Average Price Target
EUR 2.90▲(663.24% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jon Hickman | Ladenburg Thalmann & Co. | EUR 3.57 | buy | 839.37%Upside | Reiterated | 08/17/26 | ||
| Brian Kinstlinger | Alliance Global Partners | EUR 3.57→EUR 2.23 | buy | 487.11%Upside | Reiterated | 08/12/26 | ||
| Jack Vander Aarde | Maxim Group | ― | buy | ― | Reiterated | 08/07/26 | ||
| Almas Almaganbetov | Freedom Capital Markets | EUR 3.75→EUR 2.23 | hold | 487.11%Upside | Downgraded | 05/19/26 | ||
| Scott Buck | Titan Partners | EUR 5.35 | buy | 1309.06%Upside | Reiterated | 03/09/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jon Hickman | 08/17/26 | EUR 3.57 | buy | 839.37%Upside | Reiterated | Ladenburg Thalmann & Co. | ||
| Brian Kinstlinger | 08/12/26 | EUR 3.57→EUR 2.23 | buy | 487.11%Upside | Reiterated | Alliance Global Partners | ||
| Jack Vander Aarde | 08/07/26 | ― | buy | ― | Reiterated | Maxim Group | ||
| Almas Almaganbetov | 05/19/26 | EUR 3.75→EUR 2.23 | hold | 487.11%Upside | Downgraded | Freedom Capital Markets | ||
| Scott Buck | 03/09/26 | EUR 5.35 | buy | 1309.06%Upside | Reiterated | Titan Partners |
Best Analysts Covering Inuvo
Copying Jack Vander Aarde's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -7.24% per trade.
Copying Brian Kinstlinger's trades and holding each position for 1 Year would result in 30.00% of your transactions generating a profit, with an average return of -40.47% per trade.
Copying Jack Vander Aarde's trades and holding each position for 2 Years would result in 20.00% of your transactions generating a profit, with an average return of -40.83% per trade.
CD5 Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 2 | 0 |
| Buy | 0 | 1 | 1 | 1 | 0 |
| Hold | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 3 | 4 | 4 | 3 | 0 |
In the current month, CD5 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CD5 average Analyst price target in the past 3 months is 2.90.
CD5 Financial Forecast
CD5 Earnings Forecast
Next quarter’s earnings estimate for CD5 is -EUR 0.17 with a range of -EUR 0.20 to -EUR 0.13. The previous quarter’s EPS was -EUR 0.24. Its overall industry beat the EPS estimate 49.22% of the time in the past 12 months.
CD5 Sales Forecast
Next quarter’s sales forecast for CD5 is EUR 6.89M with a range of EUR 6.27M to EUR 7.25M. The previous quarter’s sales results were EUR 6.75M. Its overall industry beat sales estimates 53.85% of the time in the past 12 months.
